Evidence map›Paper›PMID 35278411›Full record

ReviewJournal of lipid research2022

The role of lipid second messengers in aldosterone synthesis and secretion.

Shinjini C Spaulding, Wendy B Bollag

Open access · goldAbstract readReview
In one paragraph

Review in Journal of lipid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Metabolic phenotypes and fatty acid profiles associated with histopathology of primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Lipid metabolism in the adrenal gland.Frontiers in endocrinology · 2025
    Review
  11. Article
  12. Sphingolipids and Chronic Kidney Disease.Journal of clinical medicine · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shinjini C SpauldingDepartment of Physiology, Medical College of Georgia at Augusta University, Augusta, GA, USA.
Wendy B BollagDepartment of Physiology, Medical College of Georgia at Augusta University, Augusta, GA, USA; Research Department, Charlie Norwood VA Medical Center, Augusta, GA, USA. Electronic address: wbollag@augusta.edu.
Augusta University · US

Funding

BLRD Research Career Scientist Award ApplicationIK6BX005691 · VA · CHARLIE NORWOOD VA MEDICAL CENTER · PI BOLLAG, WENDY B · 2021 to 2025
–
BLRD VA IK6 BX005691
6 · The paper itself

Abstract

Second messengers are small rapidly diffusing molecules or ions that relay signals between receptors and effector proteins to produce a physiological effect. Lipid messengers constitute one of the four major classes of second messengers. The hydrolysis of two main classes of lipids, glycerophospholipids and sphingolipids, generate parallel profiles of lipid second messengers: phosphatidic acid (PA), diacylglycerol (DAG), and lysophosphatidic acid versus ceramide, ceramide-1-phosphate, sphingosine, and sphingosine-1-phosphate, respectively. In this review, we examine the mechanisms by which these lipid second messengers modulate aldosterone production at multiple levels. Aldosterone is a mineralocorticoid hormone responsible for maintaining fluid volume, electrolyte balance, and blood pressure homeostasis. Primary aldosteronism is a frequent endocrine cause of secondary hypertension. A thorough understanding of the signaling events regulating aldosterone biosynthesis may lead to the identification of novel therapeutic targets. The cumulative evidence in this literature emphasizes the critical roles of PA, DAG, and sphingolipid metabolites in aldosterone synthesis and secretion. However, it also highlights the gaps in our knowledge, such as the preference for phospholipase D-generated PA or DAG, as well as the need for further investigation to elucidate the precise mechanisms by which these lipid second messengers regulate optimal aldosterone production.

Indexed as

AldosteronePhospholipase DCeramidesPhosphatidic AcidsSecond Messenger SystemsSphingolipidsAldosteroneCeramidesPhosphatidic AcidsPhospholipase DSphingolipidsadrenal cortexglycerophospholipidsintracellular signalingphospholipasesprimary aldosteronismsignal transductionsphingolipidssteroidogenesis

Identifiers

PMID35278411
PMCPMC9020094
OpenAlexW4220871118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.